−£117k
vs Apr 2024Active12549905Private limited companyHeadington
METAGUIDEX LTD
Significant control: Ryan Charles Pink (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Metaguidex Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Metaguidex Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
METAGUIDEX LTD is an active private limited company (company number 12549905) incorporated on 7 April 2020, registered in Headington. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 April 2025, showing net assets of −£117k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 8% on the prior period (−£109k).
Peer position · net assets
By net assets it sits in the bottom quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Dr Ryan Charles Pink
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr David Raul Francisco Carter
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 7 April 20206 yrs ago
- Next accounts due
- 30 January 2027in 97 days
- Confirmation statement due
- 21 April 2027in 178 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
vs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | −£117k | — | — | £29k | — | — | 0 |
| 30 April 2024 | −£109k | — | — | £22k | — | — | 0 |
Current ratio0.05Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-117,330 at 30 April 2025
- Current assets below creditors within one yearCurrent ratio 0.05
- Incorporated five or more years agoIncorporated 7 April 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 178 days
- Next accounts duein 97 days
- Accounts period endNet liabilities £117k · micro accounts
- Accounts period endNet liabilities £109k · micro accounts
- Incorporated
08
Similar companies in Oxford
- LATUS THERAPEUTICS LIMITEDOxford · inc. Apr 2020
- ACT THERAPEUTICS LTDOxford · inc. Mar 2020
- EREBAGEN LTDKidlington · inc. Mar 2020
- NEBUQUINE LIMITEDWitney · inc. Apr 2020
- MEDIMAB BIOTHERAPEUTICS LTDAbingdon · inc. Mar 2020
- DARK BLUE THERAPEUTICS LTDOxford · inc. Jun 2020
All companies incorporated on 7 April 2020 · in Apr 2020.
09
Reminders for METAGUIDEX LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.